Literature DB >> 27480224

Nogo-B receptor deficiency increases liver X receptor alpha nuclear translocation and hepatic lipogenesis through an adenosine monophosphate-activated protein kinase alpha-dependent pathway.

Wenquan Hu1,2, Wenwen Zhang2, Yuanli Chen2, Ujala Rana1, Ru-Jeng Teng3, Yajun Duan2, Zhong Liu1, Baofeng Zhao1, Jamie Foeckler4, Hartmut Weiler4, Rachel E Kallinger5, Michael J Thomas5, Kezhong Zhang6, Jihong Han7,8, Qing Robert Miao9.   

Abstract

Nogo-B receptor (NgBR) was identified as a specific receptor for binding Nogo-B and is essential for the stability of Niemann-Pick type C2 protein (NPC2) and NPC2-dependent cholesterol trafficking. Here, we report that NgBR expression levels decrease in the fatty liver and that NgBR plays previously unrecognized roles in regulating hepatic lipogenesis through NPC2-independent pathways. To further elucidate the pathophysiological role of NgBR in mammals, we generated NgBR liver-specific knockout mice and investigated the roles of NgBR in hepatic lipid homeostasis. The results showed that NgBR knockout in mouse liver did not decrease NPC2 levels or increase NPC2-dependent intracellular cholesterol levels. However, NgBR deficiency still resulted in remarkable cellular lipid accumulation that was associated with increased free fatty acids and triglycerides in hepatocytes in vitro and in mouse livers in vivo. Mechanistically, NgBR deficiency specifically promotes the nuclear translocation of the liver X receptor alpha (LXRα) and increases the expression of LXRα-targeted lipogenic genes. LXRα knockout attenuates the accumulation of free fatty acids and triglycerides caused by NgBR deficiency. In addition, we elucidated the mechanisms by which NgBR bridges the adenosine monophosphate-activated protein kinase alpha signaling pathway with LXRα nuclear translocation and LXRα-mediated lipogenesis.
CONCLUSION: NgBR is a specific negative regulator for LXRα-dependent hepatic lipogenesis. Loss of NgBR may be a potential trigger for inducing hepatic steatosis. (Hepatology 2016;64:1559-1576).
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27480224      PMCID: PMC5074877          DOI: 10.1002/hep.28747

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  36 in total

Review 1.  AMPK: positive and negative regulation, and its role in whole-body energy homeostasis.

Authors:  D Grahame Hardie
Journal:  Curr Opin Cell Biol       Date:  2014-09-26       Impact factor: 8.382

2.  Mutation of Nogo-B receptor, a subunit of cis-prenyltransferase, causes a congenital disorder of glycosylation.

Authors:  Eon Joo Park; Kariona A Grabińska; Ziqiang Guan; Viktor Stránecký; Hana Hartmannová; Kateřina Hodaňová; Veronika Barešová; Jana Sovová; Levente Jozsef; Nina Ondrušková; Hana Hansíková; Tomáš Honzík; Jiří Zeman; Helena Hůlková; Rong Wen; Stanislav Kmoch; William C Sessa
Journal:  Cell Metab       Date:  2014-07-24       Impact factor: 27.287

3.  Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells.

Authors:  Robert Qing Miao; Yuan Gao; Kenneth D Harrison; Jay Prendergast; Lisette M Acevedo; Jun Yu; Fenghua Hu; Stephen M Strittmatter; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-11       Impact factor: 11.205

4.  Nogo-B receptor is essential for angiogenesis in zebrafish via Akt pathway.

Authors:  Baofeng Zhao; Changzoon Chun; Zhong Liu; Mark A Horswill; Kallal Pramanik; George A Wilkinson; Ramani Ramchandran; Robert Q Miao
Journal:  Blood       Date:  2010-09-02       Impact factor: 22.113

Review 5.  Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease.

Authors:  Hye-Jin Yoon; Bong Soo Cha
Journal:  World J Hepatol       Date:  2014-11-27

Review 6.  Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.

Authors:  Anna C Calkin; Peter Tontonoz
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-14       Impact factor: 94.444

7.  Cholesteryl ester hydroperoxides increase macrophage CD36 gene expression via PPARalpha.

Authors:  Iness Jedidi; Martine Couturier; Patrice Thérond; Monique Gardès-Albert; Alain Legrand; Robert Barouki; Dominique Bonnefont-Rousselot; Martine Aggerbeck
Journal:  Biochem Biophys Res Commun       Date:  2006-11-03       Impact factor: 3.575

8.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

9.  A new role for Nogo as a regulator of vascular remodeling.

Authors:  Lisette Acevedo; Jun Yu; Hediye Erdjument-Bromage; Robert Qing Miao; Ji-Eun Kim; David Fulton; Paul Tempst; Stephen M Strittmatter; William C Sessa
Journal:  Nat Med       Date:  2004-03-21       Impact factor: 53.440

10.  Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.

Authors:  Yuan Zhang; Sarah R Breevoort; Jerry Angdisen; Mingui Fu; Daniel R Schmidt; Sam R Holmstrom; Steven A Kliewer; David J Mangelsdorf; Ira G Schulman
Journal:  J Clin Invest       Date:  2012-04-09       Impact factor: 14.808

View more
  8 in total

1.  25-Hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism.

Authors:  Ying Liu; Zhuo Wei; Xingzhe Ma; Xiaoxiao Yang; Yuanli Chen; Lei Sun; Chuanrui Ma; Qing R Miao; David P Hajjar; Jihong Han; Yajun Duan
Journal:  J Lipid Res       Date:  2018-01-03       Impact factor: 5.922

2.  Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins.

Authors:  Wenwen Zhang; Xiaoxiao Yang; Yuanli Chen; Wenquan Hu; Lipei Liu; Xiaomeng Zhang; Mengyang Liu; Lei Sun; Ying Liu; Miao Yu; Xiaoju Li; Luyuan Li; Yan Zhu; Qing Robert Miao; Jihong Han; Yajun Duan
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-12-05       Impact factor: 4.698

3.  Functional interplay between liver X receptor and AMP-activated protein kinase α inhibits atherosclerosis in apolipoprotein E-deficient mice - a new anti-atherogenic strategy.

Authors:  Chuanrui Ma; Wenwen Zhang; Xiaoxiao Yang; Ying Liu; Lipei Liu; Ke Feng; Xiaomeng Zhang; Shu Yang; Lei Sun; Miao Yu; Jie Yang; Xiaoju Li; Wenquan Hu; Robert Q Miao; Yan Zhu; Luyuan Li; Jihong Han; Yuanli Chen; Yajun Duan
Journal:  Br J Pharmacol       Date:  2018-03-23       Impact factor: 8.739

4.  Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase.

Authors:  Marco De Giorgi; Kelsey E Jarrett; Jason C Burton; Alexandria M Doerfler; Ayrea Hurley; Ang Li; Rachel H Hsu; Mia Furgurson; Kalyani R Patel; Jun Han; Christoph H Borchers; William R Lagor
Journal:  J Lipid Res       Date:  2020-10-27       Impact factor: 5.922

5.  ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy.

Authors:  Yuan Tian; Bin Yang; Weinan Qiu; Yajing Hao; Zhenxing Zhang; Bo Yang; Nan Li; Shuqun Cheng; Zhangjun Lin; Yao-Cheng Rui; Otto K W Cheung; Weiqin Yang; William K K Wu; Yue-Sun Cheung; Paul B S Lai; Jianjun Luo; Joseph J Y Sung; Runsheng Chen; Hong-Yang Wang; Alfred S L Cheng; Pengyuan Yang
Journal:  Nat Commun       Date:  2019-07-29       Impact factor: 14.919

Review 6.  Research advances on neurite outgrowth inhibitor B receptor.

Authors:  Rui Zhang; Bei-Sha Tang; Ji-Feng Guo
Journal:  J Cell Mol Med       Date:  2020-06-15       Impact factor: 5.310

7.  Nogo-B promotes tumor angiogenesis and provides a potential therapeutic target in hepatocellular carcinoma.

Authors:  Hao Cai; Hexige Saiyin; Xing Liu; Dingding Han; Guoqing Ji; Bo Qin; Jie Zuo; Suqin Shen; Wenbo Yu; Jiaxue Wu; Yanhua Wu; Long Yu
Journal:  Mol Oncol       Date:  2018-10-26       Impact factor: 6.603

8.  Peroxisome Proliferator-Activated Receptor-Gamma Reduces ER Stress and Inflammation via Targeting NGBR Expression.

Authors:  Jialing Ma; Peng Zeng; Lipei Liu; Mengmeng Zhu; Juan Zheng; Chengyi Wang; Xiaokang Zhao; Wenquan Hu; Xiaoxiao Yang; Yajun Duan; Jihong Han; Qing R Miao; Yuanli Chen
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.